Abstract
Adherence to antidiabetic medications (ADMs) remains a serious challenge among type 2 diabetes mellitus (T2DM) patients. Factors affecting medication adherence are not fully understood in Nigeria. This qualitative study explored patients’ views on barriers and facilitators of medication adherence. Data collection was through face-to-face, semistructured, in-depth interviews conducted on 25 purposively sampled patients attending a public tertiary hospital. The interviews were audio recorded, transcribed verbatim, and analyzed using thematic analysis based on socioecological framework. NVIVO version 10 identified more codes. Most commonly identified barriers were organizational (clinic structure), personal (perception of T2DM as a dangerous illness), interpersonal (lack of spousal support), and community (concerns about taking ADMs in social gatherings). It was observed that female patients received more spousal support than the males. The facilitators of adherence include perceiving medication-taking a routine, the need to live longer, having savings for ADMs, purchasing medications to last until the next clinic visit. This study identified barriers and facilitators unique to Nigerian T2DM patients. Interventions anchored on these factors would improve medication adherence.
Introduction
Diabetes is among the noncommunicable diseases with far-reaching social, health, and economic consequences. It is a major health concern affecting an increasing number of individuals and nations around the globe, with over 425 million of the world population currently having diabetes (1). In Nigeria, the diabetes is on the increase, and type 2 diabetes mellitus (T2DM) is the most prevalent, accounting for about 90% to 95% of the whole diabetes population (2,3). Contributing to T2DM burden are the complications arising from prolonged hyperglycemia due to nonadherence to antidiabetic medications (ADMs) (4).
Adherence to medications has historically and significantly remained the subject of discussion globally. Despite its role in diabetes management, available streams of evidence show that adherence to ADMs is low (5 –7). Nonadherence contributes to the worsening of the disease, increased hospital admissions, and high medical cost (8). Based on this evidence, improving adherence among T2DM patients is of utmost importance and may require patients’ views, yet studies exploring barriers to adherence from patients’ perspective in Nigeria are few. Qualitative studies assist in understanding patients’ lived experiences and the meaning they attached to them. They often uncover new facts that could serve as potential targets for interventions. Unfortunately, much of the adherence studies done until this point have been largely quantitative (9,10). Some qualitative studies have identified cultural, religious, health providers factors, system-related factors, perceived safety, and necessity of the medication as factors contributing to nonadherence (11 –13). However, there is paucity of research exploring the interplay/interrelationship of the determinants of adherence among type 2 diabetes patients using socioecological models. The use of socioecological models has been advocated in adherence studies (14). They not only assist in identifying multiple underlying causes of nonadherence but also provide the reasons behind the behavior that could serve as potential targets for intervention (15). The model assumes that interventions targeted at contextual factors such as social and environmental barriers will support behavioral changes in an individual. Therefore, given the complexity and dynamic nature of adherence, tackling the problem of nonadherence requires socioecological perspectives. The aim of the study was to explore patients’ experience of living with diabetes and taking their prescribed medication.
Methods
Study Design
An exploratory design was employed to gain adequate insight into factors influencing medication adherence.
Sampling and Recruitment of Patients
This study recruited T2DM patients attending the diabetic clinic of a public tertiary hospital in Lagos, Nigeria. It is a referral clinic that runs once a week for follow-up cases with an average of 60 patients per day. Patients’ vitals are checked by the nurses before they are lined up to see the clinicians. Medication adherence was assessed using a pretested adherence measuring scale. Both adherent and nonadherent patients aged 18 years and older and using at least 1 ADM were purposively selected and invited for an in-depth interview. The sample selected varied in terms of age, sex, educational levels, ethnic groups, and disease duration in order to get a diverse opinion on factors affecting medication adherence. Theme saturation was achieved with 25 patients.
Data Collection
Face-to-face interviews were used for data collection. A semistructured interview protocol developed from a review of literature guided the interview (Table 1). The guide was reviewed by 2 experts in qualitative research and piloted on 2 patients. The pilot interviews were removed from the final interviews used for analysis. The interviews began with questions on patients’ experience with diabetes and included probes to further explore other contextual factors that impact medication adherence. The aim of this study was explained, and patients signed an informed consent form. Patients’ demographic information was collected using a data collection form. The interviews were conducted by the researcher, who is a pharmacist in academia, and have undergone some trainings on qualitative methods. The interviews took place at different locations of their choice away from the clinic to allow free discussions. The interviews were conducted from October 2017 to September 2018 and lasted between 35 and 60 minutes.
Interview Guide.
Data Analysis
The audio-recorded interviews were transcribed verbatim. The transcripts were analyzed using thematic analysis—the framework approach (16). The transcripts were read repeatedly for familiarization and understanding of the content. Two independent researchers coded 2 transcripts independently using in vivo codes. The coders met, discussed, and resolved discrepancies. The coding matrix was developed and applied subsequently to the remaining 23 transcripts. NVIVO version 10 was used for more identification of codes and data storage. The intercoder reliability of the 2 coders was computed. The Cohen’s κ ranged from .78 to 1. The average level of consistency of the questions was 0.89. Codes were collated into subthemes and themes, subsequently refined, defined, and charted onto a table following the structure developed a priori to the socioecological framework (15).
Results
Fourteen female (56%) and 11 male (44%) patients participated in the study, with age ranging from 32 to 70 years. The demographic characteristics of the patients are presented in Table 2. The barriers to medication adherence composed of 4 level factors (personal, interpersonal, organizational, and community; Table 3; Figure 1).
Overview of Demographic Characteristics of the Study Patients.
Abbreviation: LGA, local government area.
Description of the Themes, Subthemes, and Codes Based on the Socioecological Framework.
Abbreviations: ADMs, antidiabetic medications; HCP, health care provider.
Barriers to medication adherence based on socioecological framework. Adapted from Berben et al (17).
Personal-Level Barriers
Patients’ Perception of Diabetes and ADMs
Patients described their traumatized experiences before and during the diagnosis of diabetes. They perceived type 2 diabetes as a severe and dangerous illness that had no cure. This led to some patients relying on God for intervention, while they had reduced urge for their ADMs: A female patient noted: “Diabetes is a disease that can kill someone if not managed very well. Once diabetes is in your body, it is only God’s intervention that can treat it” (IDI_4, female 58 years). For some patients, the perception of diabetes as a dangerous illness and poor awareness of the symptoms made them initiate the prescribed medications immediately. The manner of disclosure of the patients’ diabetes status by the health care providers (HCPs) played a role on how patients received the news and their subsequent perception of the illness: “I was sent for blood test to know why I am sick… from the test, the Doctor said you’re in difficulty o, blah blah! Your sugar is high” (IDI_3, female, 70 years). Hence, breaking the news to them in this manner suggests that they may not likely survive the illness, contributing to the severity of the patient’s experience. Most patients seem to be burdened emotionally; they were sad and tired of taking the ADMs: “The fact that the illness is there forever makes me feel very sad, at times I don’t feel like taking your medications, I am just tired, and down in spirit” (IDI_10, male 54 years). Some had the fear of hypoglycemia and weight gain, which made them reduce the doses of their ADMs: “The need to control my weight makes me not to eat and not to take medications” (IDI_6, female 45 years). The patients generally expressed divergent opinions regarding the efficacy of their ADMs; some were cognizant of the efficacy of the ADMs, while others doubted whether their ADMs work: “I don’t know if my medication is helping, I did test three times last year, they said my sugar is not controlled” (IDI_7, male, 47 years). Lack of finance was a major factor that hindered adherence. Most patients lamented on how lack of money has prevented them from purchasing their ADMs: “There are times the drug will finish and there is no money, I may miss a day or 2 without taking the drugs” (IDI_23, female, 65 years).
Interpersonal Barriers
Lack of Family/HCPs Support
This study revealed that a lack of spousal and HCPs support hindered adherence to ADMs and added a variable “gender difference” in the perception of spousal support. While men perceived spousal support mainly as emotional support, having a wife conscious of their illness and prepares healthy meals. The males complained more of lack of support, and those who lacked assistance in meal preparation lamented how eating unhealthy meals caused a spike in their glucose level. Having delayed meals contributed to delay in medication-taking: “Failing to eat my meal at the right time will delay the time I am to take my drugs” (IDI_10, male, 54 years). On the contrary, women viewed support more of monetary support and received more support from their husbands. While most patients reported displeasure regarding HCPs poor attitude and poor communication, some complained that the clinicians gave instructions without caring whether patients understood or not: “The truth is that nobody cares for you, they are only just giving medicine, if you understand, if you don’t understand, that’s your business” (IDI_13, female. 41 years). Patients expected support from HCPs but did not receive such: “Buying the medication is not a problem but one needs support from your doctor, pharmacist, the nurse but it’s not so” (IDI_3, female, 70 years).
Organizational Barriers
The Clinic Structure
Having overcrowded clinics, delays in purchasing ADMs from the pharmacy, having long clinic appointments, multiple prescribers, and high cost of medications were some organizational barriers that directly/indirectly affected adherence. Most patients expressed concern about seeing different doctors at different times who gave conflicting medication instructions: “Seeing different doctors that are saying different things is not right. Not reading your case file and not asking questions from it is affecting me” (IDI_4, female, 58 years). The distractions from drug company detailers marketing their ADMs during clinic hours were remarkably echoed by some patients. While female patients seem to be more disturbed about this distraction, and the lack of HCPs’ attention, the males had more challenges with HCPs’ poor attitude. The high cost of the ADMs resulted in delayed access, complementary use of herbal remedies, and poor adherence: “I do take my drugs, but now since you know how the country is, the drugs are so costly, so I had to go on my herbs” (IDI_15, male 52 years). Of note is that the use of herbals was common during the rains compared to the dry season when patients resorted back to their ADMs: “I am currently on herbal concoction but during the dry season, I will still go back to that of my tablets” (IDI_25, female 48 years).
Community Influence
Social Embarrassment and Stigma
Type 2 diabetes patients reported their inability to fit into the community for concerns of taking medication in the public. So, they kept their diabetes status a secret: “People do not even know I have diabetes, and I don’t give them the impression that I have it” (IDI_7, male, 47 years). A female participant noted: “I will not like people in the office to know…. Ah, Mrs X, you like to be take drug! Which type of drug? No, no, no, it’s only my husband that is aware” (IDI_13, female 41 years). Patients also felt devalued by some HCPs who on few occasions talk to them in a derogatory manner: “The way some nurses will shout at you and the way they behave, if you are looking at all those things, you will just go home and die” (IDI_10, male 54 years).
Facilitators of Medication Adherence
Three major themes were identified: positive perceptions, decision-making, and family support (Table 4; Figure 2).
Themes and Subthemes of Facilitators of Medication Adherence.
Abbreviation: ADMs, antidiabetic medications.
Facilitators of antidiabetic medications adherence among type 2 diabetes mellitus patients.
Positive Perception
A unique factor that motivated patients to adhere to their medications was the perceived need to live longer and having a positive mindset toward diabetes: “You have to make up your mind that you want to live, I don’t have money but when I realize that I must live I have to make out time to buy the drugs as at when due” (IDI_2, female, 50 years).
Decision to Have Reminders, Save, and Purchase Sufficient ADMs
Patients who perceived medication-taking as a routine used meals and alarms as reminders, had savings for their medications, and bought their medications to last till the next clinic appointment had tendencies to adhere: “I have to take it in the morning, I am just used to it, It has become a normal life routine” (IDI_3, female, 70 years); “I save a lot to be able to buy my glucose drugs” (IDI_24, female, 49 years). Female patients who have had diabetes for more than 10 years expressed mastery of skills than males. Interestingly, glucose levels serve both as a barrier and a facilitator; while high glucose prompts medication-taking, a low or normal glucose delays medication-taking: “Sometimes, when I check my blood sugar and its ok, I won’t take the drugs till the following day” (IDI_4, female, 58 years).
Family Support
Patients who received emotional, practical, and financial support from family members and spouses had better adherence: A man reported: “The advice and encouragement from my wife and my children help me, their words keep me going” (IDI_10, male, 54 years). A woman noted: “My children help me in the kitchen at times to cook; when I am tired; my husband helps me to buy the drugs” (IDI_14, female, 50 years).
Discussion
This study is among the few Nigerian studies that explored both barriers and facilitators of medication adherence using the socioecological model. From the socioecological perspective, the identification of barriers to medication adherence that go beyond the personal barriers to other environmental factors such as the family, community, HCPs, and organizational barriers is crucial for intervention. Medication adherence is often viewed as being affected by and affecting the social environment (15,17,18). Therefore studies that focused mostly on patient-related factors provide an incomplete picture of factors influencing adherence.
In this study, organizational level barriers were frequently reported, with most patients complaining about the clinic structure (overcrowded clinic, long clinic appointments, missing case files, having multiple prescribers), poor patients–HCPs communication, limited access, and cost of ADMs. Of note is that poor access and high cost of ADMs made patients resort to herbal remedies which are complimentary and seasonal. Therefore, it is not surprising that this study recorded numerous organizational barrier that directly or indirectly impacted adherence (19). Having multiple prescribers, long clinic appointments, and missing case files evident in this study contributes to lack of continuity in care, which is a major component of the chronic care model stipulated by Wagner et al (20). Unfortunately, in Nigeria, most tertiary hospitals depict an acute care model for chronic illnesses resulting in fragmented care.
Perceptions of T2DM as a very severe illness, doubt about the efficacy of prescribed ADMs, emotional burden, forgetfulness, and poor attitude (carelessness) were the prominent personal barriers that affected medication adherence. Illness perception is one of the psychosocial factors that is generally believed to positively influence medication adherence and refers to the image patients formed from their experience with diabetes and affects motivation to adhere (21,22).
This study identified some knowledge gaps among the patients, as many patients erroneously attributed diabetes symptoms to Malaria—a parasitic disease endemic in Nigeria. This knowledge gaps resulted in the turbulent diabetes diagnosis. The influence of knowledge and perception of diabetes on adherence documented in this study is consistent with previous studies (12,13,21). This emphasizes the need to address perceptual barriers during counseling (22).
Although there are conflicting pieces of evidence regarding the role of family on medication adherence (23 –25), this study highlighted the strategic role of the family in enhancing medication adherence and identified what constituted family/spousal support in Nigeria. Family members being conscious of the patients’ illness, spouses/or children serving as reminders to take ADMs, providing money for ADMs, meal preparation, and emotional support were the prominent spousal support peculiar to these patients. A gender difference in spousal support emerged, which hitherto has not been documented previously. While men expressed more of dietary and emotional support, women considered monetary provision as support. This observation lays credence to the African traditional roles, where the women are responsible for meal preparation, and the men provided money for the family. In some other developed nations, spouses acting as a role model, engaging in grocery shopping, and reading food labels were perceived as supportive roles (23,26). Therefore, involving spouses and/or family members during clinic visits should be given a priority in diabetes management.
This study demonstrated that the community within which patients live plays a significant role in defining adherence. Patients’ concern about taking medication in public for fear of been tagged diabetic or discrimination was an important community-level factor that influenced medication-taking behavior. Previous studies have reported that patients with diabetes experience feelings of fear, embarrassment, blame, and guilt (27), which often leads to depression (28). Addressing this concern can be achieved through public enlightenment on the roles of the public in diabetes management and the demands of diabetes. Therefore, multilevel interventions targeted at the patients, community, and health care systems would improve adherence.
This study further provided unique insights into the facilitators of adherence. Patients perceiving medication-taking as routine, using breakfast/other meals as reminders, the realization of the need to live longer, having a positive mindset, and making efforts to avoid complications motivated them to adhere to medications. Some studies reported family support, having medication pill boxes, having insight of their illness, low medication burden, and having enabling environment as facilitators of medication adherence (29,30). Intervention focused on reminders have the potential to improve adherence.
This study has some limitations. Although in-depth interviews provided deeper understanding of the barriers and facilitators of medication adherence, the interviews may be prone to recall bias and social desirability.
Conclusion
Our findings revealed personal, interpersonal, organizational, and community barriers unique to Nigerian population. The consideration of the barriers and the facilitators of medication adherence should underpin clinical interventions to improve adherence.
Footnotes
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
